Sanuwave Health Inc. SNWV
5.04
0.19
3.92%
as of 25 Sep
- Market cap
- $41.7M
- P/E
- 3.0×
Follow SNWV
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (254.57%) | (213.43%) | (166.66%) | 30.70% |
+8 more TTM periods Free account |
|
| 43.82% | 48.54% | 35.02% | (33.78%) | ||
ROIC |
7.46% | 17.31% | 26.60% | 25.73% | |
Return on Tangible Assets |
209.52% | 218.00% | 134.97% | (192.10%) | |
Average Days of Receivables |
48.10 | 49.39 | 44.93 | 40.97 | |
Free Cash Flow per Share |
1.09 | 1.07 | 0.85 | 0.49 | |
Free Cash Flow |
9.37 | 9.23 | 7.31 | 4.22 | |
Capital Expenditures |
4.15 | 3.44 | 3.43 | 2.92 | |
Piotroski F-Score |
5.00 | 6.00 | 7.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
16.66% | 17.45% | 10.91% | 4.32% | |
Accounts Receivable Turnover |
9.12 | 8.99 | 10.07 | 11.04 | |
Accounts Payable Turnover |
2.85 | 2.76 | 2.89 | 2.21 | |
Inventory Turnover |
1.61 | 1.82 | 2.00 | 1.75 | |
Average Days of Payables |
115.86 | 117.51 | 117.70 | 162.35 | |
Days of Inventory on Hand |
247.63 | 208.94 | 214.83 | 277.12 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5.09% | 4.07% | 3.07% | 2.19% | |
Selling, General and Administrative Expense of Revenue |
65.53% | 63.30% | 60.82% | 63.21% | |
Share Based Compensation of Revenue |
13.37% | 12.59% | 11.01% | 12.21% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.34 | 0.35 | 0.33 | (0.13) | |
Depreciation/Fixed assets |
0.84 | 1.21 | 1.39 | 1.68 | |
Capex/Depreciation |
2.20 | 1.49 | 1.25 | 0.87 | |
Revenue per Share |
5.12 | 5.16 | 5.14 | 4.80 | |
Operating CF per Share |
0.61 | 0.67 | 0.45 | 0.15 | |
Capex per Share |
0.48 | 0.40 | 0.40 | 0.34 | |
Capex to Sales |
(0.09) | (0.08) | (0.08) | (0.07) | |
Net Profit Margin |
34.66% | 37.20% | 26.82% | (23.57%) |
Columns are period end dates